Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07117773 · ClinicalTrials.gov registry record

Changes in Hydration Status of PepsiCo Frontline Workers in a Manufacturing Facility Over the Course of Multiple Shifts

A clinical trial of Hydration Status, sponsored by PepsiCo Global R&D.

Completed
Registry status
30
Enrollment target
1
Study location

NCT07117773: Completed study of Hydration Status, sponsored by PepsiCo Global R&D.

NCT07117773 is a study of Hydration Status that has completed, run by PepsiCo Global R&D. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07117773, a study of Hydration Status, has completed, sponsored by PepsiCo Global R&D.

COMPLETED
Registry status
30 participants
Enrollment target
1
Study location

Study Summary

Physically demanding occupations (PDO) require high levels of energy expenditure, mental acuity, and technical skills. Sometimes this work is performed in extreme environments during hot/humid summer months. Previous research shows that dehydration and heat stress can increase risk of heat-related illness, reduced cognitive function, and work capacity. While this impact of physically demanding work in extreme environmental conditions is often studied in firefighters, military personnel, and athletes, and even agricultural workers, manufacturing and warehouse workers ("the industrial athlete") are underrepresented in the literature. The purpose of the study is to examine the impact hydration status of the industrial athlete (i.e., frontline manufacturing and warehouse workers at PepsiCo facilities) prior to, during, and after their shift over a typical work week has on work performance. Note: Recruitment is limited to PepsiCo Frontline Employees Only. Do not contact study official for enrollment.

Primary Outcome

USG digital pen refractometer (au)

Conditions Studied

Study Locations (1)

Florida

  • Gatorade Sports Science Institute - Bradenton

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2025-08-08
Est. Completion 2025-08-24
PepsiCo Global R&D

47 total trials

What the finished NCT07117773 record still lists

NCT07117773 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.

The record links to 1 condition, with Hydration Status appearing as the primary indexed condition, and to 0 interventions.

NCT07117773 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT07117773 about?

NCT07117773 is a clinical study titled "Changes in Hydration Status of PepsiCo Frontline Workers in a Manufacturing Facility Over the Course of Multiple Shifts". Physically demanding occupations (PDO) require high levels of energy expenditure, mental acuity, and technical skills. Sometimes this work is performed in extreme environments during hot/humid summer months. Previous research shows that dehydration and heat stress can increase risk of heat-related i...

What is the current status of trial NCT07117773?

This trial is currently completed. The enrollment target is 30 participants. The study started on 2025-08-08. Estimated completion is 2025-08-24.

What conditions does trial NCT07117773 study?

This clinical trial studies the following conditions: Hydration Status.

Who is sponsoring clinical trial NCT07117773?

This trial is sponsored by PepsiCo Global R&D, which has 47 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07117773 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hydration Status

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07117773, the US trial registry maintained by the National Library of Medicine. NCT07117773 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.